Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003292571 | SCV003985266 | uncertain significance | Inborn genetic diseases | 2023-05-09 | criteria provided, single submitter | clinical testing | The c.751A>G (p.I251V) alteration is located in exon 3 (coding exon 3) of the FGF23 gene. This alteration results from a A to G substitution at nucleotide position 751, causing the isoleucine (I) at amino acid position 251 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005012852 | SCV005635039 | uncertain significance | Autosomal dominant hypophosphatemic rickets; Tumoral calcinosis, hyperphosphatemic, familial, 2 | 2024-04-24 | criteria provided, single submitter | clinical testing |